Somi Igbene, PhD,  science writer—

Somi graduated from Imperial College London in 2011 with a PhD in cellular and molecular immunology. She worked as a medical writer at several medical communications agencies in London, including Core Medica. Besides science writing, Somi works as a registered associate nutritionist, helping adults and children improve their diets to prevent type 2 diabetes.

Articles by Somi Igbene

Optimal Subcutaneous Lecanemab Dose Found in Modeling Study

The optimal dose of under-the-skin (subcutaneous) lecanemab, Eisai’s experimental therapy for early Alzheimer’s disease, has been determined in a modeling study. The dose is currently being evaluated in the Phase 3 Clarity AD open-label extension study (NCT03887455). “Eisai’s broad clinical program for lecanemab continues to deliver data…

Brain Health Academy Will Offer Wellness Guidance to Professionals

UsAgainstAlzheimer’s is preparing to launch free online courses — The Brain Health Academy — teaching health and wellness professionals how to help people reduce the risk of Alzheimer’s and dementia. Developed in partnership with the American Heart Association, The American College of Lifestyle Medicine, and the Centers for…